Similar articles

• Translational research in oncology comes timely.

  Chow LW, Toi M. Chow LW, et al. Biomed Pharmacother. 2005 Oct;59 Suppl 2:S263. doi: 10.1016/s0753-3322(05)80041-1. Biomed Pharmacother. 2005. PMID: 16507388 No abstract available.
• Monoclonal antibodies for medical oncology: a few critical perspectives.

  Belda-Iniesta C, Ibáñez de Cáceres I, de Castro J. Belda-Iniesta C, et al. Clin Transl Oncol. 2011 Feb;13(2):84-7. doi: 10.1007/s12094-011-0623-z. Clin Transl Oncol. 2011. PMID: 21324795 Review.
• Highlights of the American Society of Clinical Oncology annual meeting 2005. 13-17 May, 2005, Florida, USA.

  Burstein HJ. Burstein HJ. Expert Rev Anticancer Ther. 2005 Aug;5(4):581-3. doi: 10.1586/14737140.5.4.581. Expert Rev Anticancer Ther. 2005. PMID: 16111459 No abstract available.
• Combination therapies in oncology.

  Webster RM. Webster RM. Nat Rev Drug Discov. 2016 Feb;15(2):81-2. doi: 10.1038/nrd.2016.3. Nat Rev Drug Discov. 2016. PMID: 26837588 No abstract available.
• Conventional cancer therapy: promise broken or promise delayed?

  Tannock IF. Tannock IF. Lancet. 1998 May;351 Suppl 2:SII9-16. doi: 10.1016/s0140-6736(98)90327-0. Lancet. 1998. PMID: 9606361 Review. No abstract available.